Markets.com Logo

AFMD

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.217$
  • Previous Close
    0.1829$
  • 52 Week Change
    8.88$
  • Day Range
    0.03$
  • 52 Week High/Low
    0.0701$ - 8.95$
  • Dividend Per Share
    --
  • Market cap
    2 975 K$
  • EPS
    -0.94
  • Beta
    2.072
  • Volume
    --

About

AFMD.US represents the common stock of Affimed N.V., a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Their proprietary ROCK platform enables the development of innate cell engagers (ICEs), designed to direct and harness the power of the innate immune system to fight cancer. Affimed's lead product candidate, AFM13, is being investigated in clinical trials for the treatment of CD30-positive lymphomas, and the company has several other ICEs in preclinical development targeting various cancers.

US Jobs Report and Fed Policy Outlook: Market Expectations and Potential Risks

Sophia Claire|--

Central Banks' Gold Rush: Why They're Piling into the Precious Metal

Liam James|--
GME stock is trading down: What is the target price for GME stock in 2025?

GME stock is trading down: What is the target price for GME stock in 2025?

Ghko B|--
RGTI Stock Price Analysis: Why Rigetti (RGTI) Stock Is Trading Higher Today?

RGTI Stock Price Analysis: Why Rigetti (RGTI) Stock Is Trading Higher Today?

Ghko B|--
XRP Price Prediction: Can Ripple (XRP/USD) Reach $4 in 2025?

XRP Price Prediction: Can Ripple (XRP/USD) Reach $4 in 2025?

Ghko B|--

Apple iPhone 17 Price Speculation & New Devices: A Closer Look at Projections

Sophia Claire|--

Goldman Sachs: Gold Could Hit $5,000 if Fed Credibility Falters

Ava Grace|--

Factors

Clinical Trial Results: Positive clinical trial outcomes typically boost investor confidence and drive up the stock price. Conversely, failed or delayed trials can negatively impact the stock.

Regulatory Approvals: Successful approval of Afmd's product candidates by regulatory agencies like the FDA can lead to increased stock value.

Partnerships and Collaborations: Strategic alliances with larger pharmaceutical companies or research institutions often signal validation of Afmd's technology and can influence stock performance.

Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector can affect Afmd's stock price, regardless of company-specific news.

Financial Performance: Afmd's cash position, revenue generation, and expenses influence investor perception and stock valuation. Strong financial results typically lead to increased confidence.

Competition: The presence of competing therapies or companies in the same therapeutic area can impact Afmd's market share and stock price.

People Also Watch

Latest news

US Job Growth Slows, Unemployment Rises: Rate Cut Outlook Intensifies

Noah Lee|--

Global Market Overview: Weak Nonfarm Data, Gold Hits Highs, OPEC+ Considers Output Hike

Emma Rose|--

US Job Growth Slows, Unemployment Rises: Fed Rate Cut Expectations Surge

Emma Rose|--

Latest Education Articles

Indices CFD Trading for beginner: Dow Jones Index, S&P 500, Nasdaq Index

Indices CFD Trading for beginner: Dow Jones Index, S&P 500, Nasdaq Index

Frances Wang|--
SoFi Technologies Inc Stock Is Rising: How to Trade Sofi Stock CFDs?

SoFi Technologies Inc Stock Is Rising: How to Trade Sofi Stock CFDs?

Frances Wang|--
Crypto CFD Trading Benefits and Risks: Ethereum, XRP, Dogecoin

Crypto CFD Trading Benefits and Risks: Ethereum, XRP, Dogecoin

Ghko B|--